Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFκB pathways in mice with endotoxin-induced acute lung injury

Food and Chemical Toxicology

Volumn 49, Issue 10, 2011, Pages 2660-2666

  Kuo, Min Yung ^a   Liao, Mao Fang ^b   Chen, Fong Lin ^c   Li, Yi Ching ^c   Yang, Ming Ling ^d   Lin, Ruey Hseng ^c   Kuan, Yu Hsiang ^c  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b FENG YUAN HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute lung injury; Lipopolysaccharide; Luteolin; MAPK; NF B

Indexed keywords

CATALASE; CD11B ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; LIPID PEROXIDATION; LUNG ALVEOLUS; LUNG EDEMA; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; PNEUMONIA; PROTEIN EXPRESSION;

ACUTE LUNG INJURY; ANIMALS; BLOOD GAS ANALYSIS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CATALASE; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; LUTEOLIN; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

MUS;

EID: 80051907838     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.07.012     Document Type: Article

References (28)

1. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 2004, 202:145-156.
2. Borregaard N., Sorensen O.E., Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007, 28:340-345.
3. Chen C.Y., Peng W.H., Tsai K.D., Hsu S.L. Luteolin suppresses inflammation- associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 2007, 81:1602-1614.
4. Del Rio D., Stewart A.J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis. 2005, 15:316-328.
5. Fan J., Ye R.D., Malik A.B. Transcriptional mechanisms of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L1037-L1050.
6. Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003, 5:1317-1327.
7. Khandoga A.G., Khandoga A., Anders H.J., Krombach F. Postischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes. Shock 2009, 31:592-598.
8. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802:396-405.
9. Kotanidou A., Xagorari A., Bagli E., Kitsanta P., Fotsis T., Papapetropoulos A., Roussos C. Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. Am. J. Respir. Crit. Care Med. 2002, 165:818.
10. Kuan Y.H., Lin R.H., Chen Y.L., Tsao L.T., Tzeng C.C., Wang J.P. Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway. Biochem. Pharmacol. 2006, 72:749-760.
11. Lee H.S., Kim H.J., Moon C.S., Chong Y.H., Kang J.L. Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir. Res. 2004, 5:23.
12. Lee J.P., Li Y.C., Chen H.Y., Lin R.H., Huang S.S., Chen H.L., Kuan P.C., Liao M.F., Chen C.J., Kuan Y.H. Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacol. Sin. 2010, 31:831-838.
13. Liu S., Feng G., Wang G.L., Liu G.J. P38 MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Eur. J. Pharmacol. 2008, 584:159-165.
14. Loke W.M., Proudfoot J.M., Stewart S., McKinley A.J., Needs P.W., Kroon P.A., Hodgson J.M., Croft K.D. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem. Pharmacol. 2008, 75:1045-1053.
15. López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini. Rev. Med. Chem. 2009, 9:31-59.
16. Lu H.W., Sugahara K., Sagara Y., Masuoka N., Asaka Y., Manabe M., Kodama H. Effect of three flavonoids, 5, 7, 3', 4'-tetrahydroxy-3-methoxy flavone, luteolin, and quercetin, on the stimulus-induced superoxide generation and tyrosyl phosphorylation of proteins in human neutrophil. Arch. Biochem. Biophys. 2001, 393:73-77.
17. Matute-Bello G., Frevert C.W., Martin T.R. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L379-L399.
18. Puneet P., Moochhala S., Bhatia M. Chemokines in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L3-L15.
19. Schuh K., Pahl A. Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury. Biochem. Pharmacol. 2009, 77:1827-1834.
20. Senftleben U., Karin M. The IKK/NF-κB pathway. Crit. Care Med. 2002, 30:18-26.
21. Shen W., Gan J., Xu S., Jiang G., Wu H. Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Pharmacol. Res. 2009, 60:296-302.
22. Sun W., Watanabe Y., Wang Z.Q. Expression and significance of ICAM-1 and its counter receptors LFA-1 and Mac-1 in experimental acute pancreatitis of rats. World J. Gastroenterol. 2006, 12:5005-5009.
23. Szarka R.J., Wang N., Gordon L., Nation P.N., Smith R.H. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J. Immunol. Methods. 1997, 202:49-57.
24. Ueda J., Starr M.E., Takahashi H., Du J., Chang L.Y., Crapo J.D., Evers B.M., Saito H. Decreased pulmonary extracellular superoxide dismutase during systemic inflammation. Free Radic. Biol. Med. 2008, 45:897-904.
25. Wang Y.A., Zhou W.X., Li J.X., Liu Y.Q., Yue Y.J., Zheng J.Q., et al. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms. Life Sci. 2005, (November 2):210-223.
26. Wheeler A.P., Bernard G.R. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-1564.
27. Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther. 2001, 296:181-187.
28. Zhang H., Slutsky A.S., Vincent J.L. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med. 2000, 26:474-476.